Publication:
Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy

dc.contributor.authorWalter P. Weberen_US
dc.contributor.authorMartin Haugen_US
dc.contributor.authorChristian Kurzederen_US
dc.contributor.authorVesna Bjelic-Radisicen_US
dc.contributor.authorRupert Kolleren_US
dc.contributor.authorRoland Reitsameren_US
dc.contributor.authorFlorian Fitzalen_US
dc.contributor.authorJorge Biazusen_US
dc.contributor.authorFabricio Brenellien_US
dc.contributor.authorCicero Urbanen_US
dc.contributor.authorRégis Resende Paulinellien_US
dc.contributor.authorJens Uwe Blohmeren_US
dc.contributor.authorJörg Heilen_US
dc.contributor.authorJürgen Hoffmannen_US
dc.contributor.authorZoltan Matraien_US
dc.contributor.authorGiuseppe Catanutoen_US
dc.contributor.authorViviana Galimbertien_US
dc.contributor.authorOreste Gentilinien_US
dc.contributor.authorMitchel Barryen_US
dc.contributor.authorTal Hadaren_US
dc.contributor.authorTanir M. Allweisen_US
dc.contributor.authorOded Olshaen_US
dc.contributor.authorMaria João Cardosoen_US
dc.contributor.authorPedro F. Gouveiaen_US
dc.contributor.authorIsabel T. Rubioen_US
dc.contributor.authorJana de Bonifaceen_US
dc.contributor.authorTor Svensjöen_US
dc.contributor.authorSusanne Bucheren_US
dc.contributor.authorPeter Dubskyen_US
dc.contributor.authorJian Farhadien_US
dc.contributor.authorMathias K. Fehren_US
dc.contributor.authorIlario Fulcoen_US
dc.contributor.authorUrsula Ganz-Blättleren_US
dc.contributor.authorAndreas Güntherten_US
dc.contributor.authorYves Harderen_US
dc.contributor.authorNik Hauseren_US
dc.contributor.authorElisabeth A. Kapposen_US
dc.contributor.authorMichael Knaueren_US
dc.contributor.authorJulia Landinen_US
dc.contributor.authorRobert Mecheraen_US
dc.contributor.authorFrancesco Meanien_US
dc.contributor.authorGiacomo Montagnaen_US
dc.contributor.authorMathilde Ritteren_US
dc.contributor.authorRamon Saccilottoen_US
dc.contributor.authorFabienne D. Schwaben_US
dc.contributor.authorDaniel Steffensen_US
dc.contributor.authorChristoph Tauschen_US
dc.contributor.authorJasmin Zeindleren_US
dc.contributor.authorSavas D. Soysalen_US
dc.contributor.authorVisnu Lohsiriwaten_US
dc.contributor.authorTibor Kovacsen_US
dc.contributor.authorAnne Tansleyen_US
dc.contributor.authorLynda Wylden_US
dc.contributor.authorLaszlo Romicsen_US
dc.contributor.authorMahmoud El-Tameren_US
dc.contributor.authorAndrea L. Pusicen_US
dc.contributor.authorVirgilio Sacchinien_US
dc.contributor.authorMichael Gnanten_US
dc.contributor.otherNew Victoria Hospital, Glasgowen_US
dc.contributor.otherChampalimaud Foundationen_US
dc.contributor.otherUniversidade Positivoen_US
dc.contributor.otherAzienda Ospedaliera Cannizzaroen_US
dc.contributor.otherIRCCS San Raffaele Scientific Instituteen_US
dc.contributor.otherKlinik St. Annaen_US
dc.contributor.otherUniklinik Düsseldorfen_US
dc.contributor.otherEnte Ospedaliero Cantonaleen_US
dc.contributor.otherUniversidad de Navarraen_US
dc.contributor.otherKaplan Medical Center Israelen_US
dc.contributor.otherKantonsspital Luzernen_US
dc.contributor.otherOrszágos Onkológiai Intézet Budapesten_US
dc.contributor.otherIstituto Europeo di Oncologiaen_US
dc.contributor.otherUniversidade Estadual de Campinasen_US
dc.contributor.otherUniversitätsspital Baselen_US
dc.contributor.otherUniversität St. Gallenen_US
dc.contributor.otherCharité – Universitätsmedizin Berlinen_US
dc.contributor.otherKristianstad Central Hospitalen_US
dc.contributor.otherUniversitat Baselen_US
dc.contributor.otherCentre Hospitalier Universitaire Vaudoisen_US
dc.contributor.otherUniversität Witten/Herdeckeen_US
dc.contributor.otherMater Misericordiae University Hospitalen_US
dc.contributor.otherBrigham and Women's Hospitalen_US
dc.contributor.otherHospital de Clinicas de Porto Alegreen_US
dc.contributor.otherKarolinska Instituteten_US
dc.contributor.otherMedizinische Universitat Wienen_US
dc.contributor.otherKlinik Hirslandenen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.contributor.otherMemorial Sloan-Kettering Cancer Centeren_US
dc.contributor.otherRoyal Liverpool and Broadgreen University Hospitals NHS Trusten_US
dc.contributor.otherHebrew University of Jerusalemen_US
dc.contributor.otherMedizinische Universität Grazen_US
dc.contributor.otherGuy's and St Thomas' NHS Foundation Trusten_US
dc.contributor.otherUniversitat Salzburgen_US
dc.contributor.otherUniversity of Sheffielden_US
dc.contributor.otherCapio S:t Görans Sjukhusen_US
dc.contributor.otherWiener Krakenanstaltenverbunden_US
dc.contributor.otherBreast Center Zürichen_US
dc.contributor.otherBreast Center St. Gallenen_US
dc.contributor.otherUniversity of Heidelbergen_US
dc.contributor.otherAraújo Jorge Hospitalen_US
dc.date.accessioned2019-08-23T10:25:39Z
dc.date.available2019-08-23T10:25:39Z
dc.date.issued2018-12-01en_US
dc.description.abstract© 2018, The Author(s). Purpose: Indications for nipple-sparing mastectomy (NSM) have broadened to include the risk reducing setting and locally advanced tumors, which resulted in a dramatic increase in the use of NSM. The Oncoplastic Breast Consortium consensus conference on NSM and immediate reconstruction was held to address a variety of questions in clinical practice and research based on published evidence and expert panel opinion. Methods: The panel consisted of 44 breast surgeons from 14 countries across four continents with a background in gynecology, general or reconstructive surgery and a practice dedicated to breast cancer, as well as a patient advocate. Panelists presented evidence summaries relating to each topic for debate during the in-person consensus conference. The iterative process in question development, voting, and wording of the recommendations followed the modified Delphi methodology. Results: Consensus recommendations were reached in 35, majority recommendations in 24, and no recommendations in the remaining 12 questions. The panel acknowledged the need for standardization of various aspects of NSM and immediate reconstruction. It endorsed several oncological contraindications to the preservation of the skin and nipple. Furthermore, it recommended inclusion of patients in prospective registries and routine assessment of patient-reported outcomes. Considerable heterogeneity in breast reconstruction practice became obvious during the conference. Conclusions: In case of conflicting or missing evidence to guide treatment, the consensus conference revealed substantial disagreement in expert panel opinion, which, among others, supports the need for a randomized trial to evaluate the safest and most efficacious reconstruction techniques.en_US
dc.identifier.citationBreast Cancer Research and Treatment. Vol.172, No.3 (2018), 523-537en_US
dc.identifier.doi10.1007/s10549-018-4937-1en_US
dc.identifier.issn15737217en_US
dc.identifier.issn01676806en_US
dc.identifier.other2-s2.0-85053429342en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/44993
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85053429342&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectMedicineen_US
dc.titleOncoplastic Breast Consortium consensus conference on nipple-sparing mastectomyen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85053429342&origin=inwarden_US

Files

Collections